Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Apr 2020 16:37

RNS Number : 6322J
Circassia Pharmaceuticals Plc
14 April 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

CIRCASSIA PHARMACEUTICALS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Harwood Capital LLP (as investment adviser/manager) and 1. Oryx International Growth Fund Limited 2. Harwood Capital LLP and 3. North Atlantic Smaller Companies Investment Trust plc

City and country of registered office (if applicable)

1. Guernsey

2. & 3. London, United Kingdom

 

4. Full name of shareholder(s) (if different from 3.)v

Name

1. Oryx International Growth Fund Limited

2. Harwood Capital LLP

3. North Atlantic Smaller Companies Investment Trust plc

 

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

9th April 2020

6. Date on which issuer notified (DD/MM/YYYY):

14th April 2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

1. 40,000,000

2. 70,000

3, 1,200,000

 

 

 

1. 10.66%

2. 0.02%

3. 0.32%

 

375,210,543

Position of previous notification (if

applicable)

1. 35,000,000

2. 70,000

 

 

 

 9.33%

 0.02%

 

 

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BJVD3B281.

1.

2.

3.

 

40,000,000

70,000

1,200,000

 

 

10.66%

0.02%

0.32%

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

41,270,000

11.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

10.66

0

10.66

Harwood Capital Management Ltd

 

 

 

Harwood Capital LLP

 

 

 

Oryx International Growth Fund Ltd

 

 

 

 

 

 

 

Christopher Harwood Bernard Mills

0.02

0

0.02

Harwood Capital Management Ltd

 

 

 

Harwood Capital LLP

 

 

 

 

 

 

 

Christopher Harwood Bernard Mills

 0.32

 

0.32

Harwood Capital Management Ltd

 

 

 

Harwood Capital LLP

 

 

 

North Atlantic Smaller Companies Investment Trust plc

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

Oxford, UK

Date of completion

14th April 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUSOVRRVUSAAR
Date   Source Headline
1st Sep 20225:45 pmRNSChange of Company Name
1st Sep 202211:00 amRNSResult of General Meeting and Change of Name
11th Aug 20227:00 amRNSProposed Change of Name and Notice of GM
29th Jul 202210:41 amRNSTotal Voting Rights
21st Jul 20223:30 pmRNSChange of Auditor
14th Jul 20227:00 amRNSTrading Update
5th Jul 20223:57 pmRNSHolding(s) in Company
30th Jun 202211:54 amRNSTotal Voting Rights
29th Jun 202211:00 amRNSUpdate regarding Beyond Air product approval
10th Jun 20221:06 pmRNSHolding(s) in Company
31st May 202211:08 amRNSTotal Voting Rights
27th May 20229:53 amRNSExtension of Block Admission
25th May 20224:41 pmRNSSecond Price Monitoring Extn
25th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20227:00 amRNSGrant of Options
12th May 202212:04 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Statement
3rd May 20224:01 pmRNSChange of Registered Office
29th Apr 202210:32 amRNSTotal Voting Rights
13th Apr 20226:17 pmRNSAnnual Report and Notice of AGM
1st Apr 20227:00 amRNSBlock listing Interim Review
1st Apr 20227:00 amRNSTotal Voting Rights
29th Mar 20222:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSBlock Admission
22nd Mar 20227:00 amRNSPreliminary Results
31st Jan 202210:24 amRNSTotal Voting Rights
28th Jan 20222:15 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSTrading Statement
4th Jan 202210:40 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20218:54 amRNSBlock Listing Application
5th Oct 20213:06 pmRNSExtension of Block Admission
30th Sep 20213:15 pmRNSBlock listing Interim Review
21st Sep 20215:18 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSDirector/PDMR Shareholding
16th Sep 20217:00 amRNSInterim Results - Ended 30 June 2021
1st Sep 20212:52 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSFirst Half Trading Update
30th Jun 202111:15 amRNSTotal Voting Rights
26th May 20217:00 amRNSSettlement Agreement reached with Beyond Air
21st May 202110:58 amRNSResult of AGM
21st May 20217:00 amRNSAGM Statement
5th May 20216:30 pmRNSHolding(s) in Company
30th Apr 202112:32 pmRNSTotal Voting Rights
21st Apr 20217:00 amRNSAnnual Report and Notice of AGM
6th Apr 202112:56 pmRNSDirector/PDMR Shareholding
1st Apr 20219:00 amRNSBlock Listing Application
31st Mar 202112:14 pmRNSBlock listing Interim Review
24th Mar 20217:01 amRNSSubscription to raise £5 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.